Advanced biologic therapies are associated with fewer adverse cardiovascular events in patients with inflammatory bowel diseases

Back

ESC Professional Premium Access

Advanced biologic therapies are associated with fewer adverse cardiovascular events in patients with inflammatory bowel diseases

Session: Autoimmune and chronic inflammatory disorders and heart disease (2)

Topic: Autoimmune/Chronic Inflammatory Disorders and Heart Disease

Speaker: Doctor T. Harb (Baltimore, US)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Tarek Harb

The Johns Hopkins University School of Medicine, Baltimore (United States of America)

0 follower

8 more presentations in this session

Chronic inflammation is associated with impaired cardiac structure and function in patients with inflammatory arthritis: the ARTCADIA Study

Speaker: Doctor M. Sengelov (Hellerup, DK)

Vascular thrombosis and relapse-associated factors in Behcet's syndrome: a comprehensive analysis of 136 patients

Speaker: Doctor S. Chadli (Rabat, MA)

The potential effects of methotrexate on cardiovascular outcomes in rheumatoid arthritis patients: a multi-institutional analysis

Speaker: Doctor M. Cervantes (Dallas, US)

Association of inflammation with left ventricular mass index in patients with rheumatoid arthritis

Speaker: Doctor A. Linde (Oslo, NO)

Cardiac structure and function in patients with chronic obstructive pulmonary disease

Speaker: Doctor D. Vesterlev (Copenhagen, DK)

Access the full session

Autoimmune and chronic inflammatory disorders and heart disease (2)

Speakers: Doctor T. Harb, Doctor M. Sengelov, Doctor S. Chadli, Doctor M. Cervantes, Doctor A. Linde...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources